Trademark: 97855551
Word
RAZTAMRI
Status
Pending
Status Code
689
Status Date
Wednesday, May 22, 2024
Serial Number
97855551
Mark Type
4
Filing Date
Friday, March 24, 2023
Published for Opposition
Tuesday, May 14, 2024
Trademark Owner History
SYROS Pharmaceuticals, Inc. - Owner At Publication
Classifications
5 pharmaceuticals for treatment of myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, acute myelogenous leukemia, and acute nonlymphocytic leukemia
Trademark Events
Mar 28, 2023
New Application Entered
Apr 16, 2023
New Application Office Supplied Data Entered
Dec 19, 2023
Assigned To Examiner
Dec 24, 2023
Non-Final Action Written
Dec 24, 2023
Non-Final Action E-Mailed
Dec 24, 2023
Notification Of Non-Final Action E-Mailed
Apr 10, 2024
Notification Of Examiners Amendment E-Mailed
Apr 10, 2024
Examiners Amendment -Written
Apr 10, 2024
Examiners Amendment E-Mailed
May 7, 2024
Teas Petition To Director Received
Apr 10, 2024
Examiner's Amendment Entered
Apr 10, 2024
Approved For Pub - Principal Register
Apr 24, 2024
Notification Of Notice Of Publication E-Mailed
May 14, 2024
Published For Opposition
May 22, 2024
Withdrawn From Issue - Petitions Office Request
May 14, 2024
Official Gazette Publication Confirmation E-Mailed
WE MAKE IT BETTER
97855552
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov